8-K - Aurinia Pharmaceuticals Inc. (0001600620) (Filer)
Aurinia Pharmaceuticals Inc.（CIK 0001600620）于 2026-10-30 提交 8-K，报告期同为 2026-10-30，文件共 13 份文档。该 8-K 涉及 Item 2.02（经营业绩与财务状况）和 Item 9.01（财务报表与附件）。公司地址为加拿大埃德蒙顿，SIC 分类为 2834 药品制剂。
报错 · 内容有误？请告诉我们。
Filing Date
2026-10-30
Accepted
2026-10-30 08:03:31
Documents
13
Period of Report
2026-10-30
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits
Mailing Address #140, 14315 - 118 AVENUE EDMONTON A0 T5L 4S6
Business Address #140, 14315 - 118 AVENUE EDMONTON A0 T5L 4S6 250-744-2487
Aurinia Pharmaceuticals Inc. (Filer) CIK: 0001600620 (see all company filings)
EIN.: 981231763 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36421 | Film No.: 261504486
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)
来源：SEC EDGAR 8-K · sec.gov